243 related articles for article (PubMed ID: 26364887)
1. Modulation of therapeutic sensitivity by human papillomavirus.
Swick AD; Chatterjee A; De Costa AM; Kimple RJ
Radiother Oncol; 2015 Sep; 116(3):342-5. PubMed ID: 26364887
[TBL] [Abstract][Full Text] [Related]
2. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
[TBL] [Abstract][Full Text] [Related]
3. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Bristol ML; James CD; Wang X; Fontan CT; Morgan IM
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
[TBL] [Abstract][Full Text] [Related]
5. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
Smith EM; Rubenstein LM; Ritchie JM; Lee JH; Haugen TH; Hamsikova E; Turek LP
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2087-96. PubMed ID: 18708401
[TBL] [Abstract][Full Text] [Related]
6. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
Combes JD; Franceschi S
Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
[TBL] [Abstract][Full Text] [Related]
7. Biological and clinical aspects of HPV-related cancers.
Szymonowicz KA; Chen J
Cancer Biol Med; 2020 Nov; 17(4):864-878. PubMed ID: 33299640
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus seropositivity and risks of head and neck cancer.
Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
[TBL] [Abstract][Full Text] [Related]
9. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
Gheit T; Anantharaman D; Holzinger D; Alemany L; Tous S; Lucas E; Prabhu PR; Pawlita M; Ridder R; Rehm S; Bogers J; Maffini F; Chiocca S; Lloveras B; Kumar RV; Somanathan T; de Sanjosé S; Castellsagué X; Arbyn M; Brennan P; Sankaranarayanan R; Pillai MR; Gangane N; Tommasino M;
Int J Cancer; 2017 Jul; 141(1):143-151. PubMed ID: 28369859
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus in archival head and neck cancer in the eastern Inner Mongolian Autonomous Region, China.
Wu E; An G; Wu R; Tang Y; Li Q; Wang J; Ling Y; You J
Tumori; 2020 Oct; 106(5):369-377. PubMed ID: 32066343
[TBL] [Abstract][Full Text] [Related]
11. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
[TBL] [Abstract][Full Text] [Related]
13. HPV, hypoxia and radiation response in head and neck cancer.
Göttgens EL; Ostheimer C; Span PN; Bussink J; Hammond EM
Br J Radiol; 2019 Jan; 92(1093):20180047. PubMed ID: 29493265
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
Smith EM; Pawlita M; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
Int J Cancer; 2010 Jul; 127(1):111-7. PubMed ID: 19876924
[TBL] [Abstract][Full Text] [Related]
15. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
Speel EJ
Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
[TBL] [Abstract][Full Text] [Related]
16. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.
Wieking BG; Vermeer DW; Spanos WC; Lee KM; Vermeer P; Lee WT; Xu Y; Gabitzsch ES; Balcaitis S; Balint JP; Jones FR; Lee JH
Cancer Gene Ther; 2012 Oct; 19(10):667-74. PubMed ID: 22918471
[TBL] [Abstract][Full Text] [Related]
17. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers.
Bol V; Grégoire V
Biomed Res Int; 2014; 2014():696028. PubMed ID: 24804233
[TBL] [Abstract][Full Text] [Related]
18. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
[TBL] [Abstract][Full Text] [Related]
19. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Bzhalava Z; Arroyo Mühr LS; Dillner J
Vaccine; 2020 May; 38(25):4066-4070. PubMed ID: 32362526
[TBL] [Abstract][Full Text] [Related]
20. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins.
Park JW; Shin MK; Pitot HC; Lambert PF
PLoS One; 2013; 8(9):e75056. PubMed ID: 24086435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
